PRECISE Phenotyping to Guide Therapies for Coronary Microvascular Dysfunction
NCT07533747
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Coronary Microvascular Dysfunction (CMD)
Interventions
DRUG:
Empagliflozin 10mg OD
Sponsor
King's College London
Collaborators
[object Object]